GlobeNewswire 2019-06-26 XBiotech Wins “Commercial Real Estate Award for Industrial Development” for its Headquarters in Aust...
GlobeNewswire 2019-06-25 XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis ...
GlobeNewswire 2019-06-11 XBiotech Added to Russell 3000® Index
GlobeNewswire 2019-06-04 XBiotech Announces Closing of Public Offering of Common Shares
GlobeNewswire 2019-05-31 XBiotech Announces Pricing of Public Offering of Common Shares
GlobeNewswire 2019-05-30 XBiotech Announces Public Offering of Common Shares
GlobeNewswire 2019-05-23 XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativ...
GlobeNewswire 2019-05-02 XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Stud...
GlobeNewswire 2019-04-09 Research Report Identifies Net 1 UEPS Technologies, XBiotech, Rambus, Vector Group, Collectors Unive...
GlobeNewswire 2019-03-05 Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradeni...
GlobeNewswire 2019-03-01 Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis...
GlobeNewswire 2019-01-29 Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting
GlobeNewswire 2019-01-28 Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology A...
GlobeNewswire 2019-01-23 Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain
GlobeNewswire 2018-12-13 XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study
GlobeNewswire 2018-12-12 XBiotech’s Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease
GlobeNewswire 2018-12-03 XBiotech Announces Successful Completion of GMP Audit
GlobeNewswire 2018-10-24 XBiotech Announces Dismissal of Securities Class Action Suit
GlobeNewswire 2018-09-26 XBiotech Announces Granting of European Patent for Treatment of Inflammatory Skin Diseases
GlobeNewswire 2018-09-24 XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab ...
GlobeNewswire 2018-09-20 XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team
GlobeNewswire 2018-09-19 Antibody Discovery Services and Platforms Market, 2028
GlobeNewswire 2018-09-13 XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot S...
GlobeNewswire 2018-09-12 XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory...
GlobeNewswire 2018-08-27 XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in...